METTL3 and neoplasm: METTL3 relies on m6A modification to affect tumor cell drug resistance at multiple levels, including expression of anticancer drug targets and multidrug transporter proteins, classical signaling pathway switches, cellular antioxidant effects, DNA damage repair, cellular autophagy, and apoptosis (Fig. 7).